InvestorsHub Logo
icon url

goupupup

07/13/20 2:18 PM

#2751 RE: bbhuey #2749

bb.. This is the same stem cells that they sold to Helios, as an extra product to deal with eyes-mac degeneration.. It does have merit, as there will be a revenue stream - royalties. Something like this might be 8-12% of sales. Plus a license fee to
sell the product in US, or wherever.